Security key
83422E204
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)
CUSIP: 83422E204
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 307,024
- Total 13F value
- $623,259
- Share change
- +307,024
- SEC-reported price per share
- $2.03
- Number of holders
- 1
- Value change
- +$623,259
- Number of buys
- 1
- Shares outstanding
- 101,143,916
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
1
Top holders
1
SLDB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2020
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83422E204
Recent filing periods:
Ownership snapshot
Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 6.7%
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 6.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
PERCEPTIVE ADVISORS LLC
6.7%
RA CAPITAL MANAGEMENT, L.P.
4.5%
Bain Capital Life Sciences Invest...
3.8%
BlackRock Finance, Inc.
2.3%
Artal Group S.A.
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
6.7%
|
$19,777,000
6,749,803 shares
|
— | 30 Jun 2020 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
4.5%
|
$13,394,000
4,571,164 shares
|
— | 30 Jun 2020 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
3.8%
|
$11,343,000
3,871,164 shares
|
— | 30 Jun 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
2.3%
|
$6,767,000
2,309,798 shares
|
— | 30 Jun 2020 |
| Artal Group S.A. |
13F
Company
|
1.8%
|
$5,274,000
1,800,000 shares
|
— | 30 Jun 2020 |
| Boxer Capital, LLC |
13F
Company
|
1.5%
|
$4,488,000
1,531,872 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
307,024
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q1 2026 Across Filers
Q1 2026 holders
143
Q3 2020 holders
1
Holder diff
-142
| Investor | Q1 2026 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend